{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:45:51Z","timestamp":1791747951524,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clim.2026.110780","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:18:53Z","timestamp":1790723933000},"page":"110780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TIGIT regulates CD8+T cell exhaustion via the PI3K\/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"288","author":[{"given":"Ruiheng","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengqian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clim.2026.110780_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.clim.2026.110780_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9840","article-title":"KRAS allelic variants in biliary tract cancers","volume":"7","author":"Moffat","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.clim.2026.110780_bb0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41418-024-01407-1","article-title":"The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma","volume":"32","author":"Liu","year":"2025","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.clim.2026.110780_bb0020","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1245\/s10434-025-17515-2","article-title":"Hepatopancreatoduodenectomy for extrahepatic cholangiocarcinoma: a series of 100 consecutive cases from an expert center in Japan","volume":"32","author":"Sugiura","year":"2025","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.clim.2026.110780_bb0030","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/curroncol30020166","article-title":"Recent updates on local ablative therapy combined with chemotherapy for extrahepatic cholangiocarcinoma: photodynamic therapy and radiofrequency ablation","volume":"30","author":"Inoue","year":"2023","journal-title":"Curr. Oncol."},{"issue":"9","key":"10.1016\/j.clim.2026.110780_bb0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jamaoncol.2025.1926","article-title":"Adjuvant chemoradiation and immunotherapy for extrahepatic cholangiocarcinoma and gallbladder cancer: a randomized clinical trial","volume":"11","author":"Xiao","year":"2025","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.clim.2026.110780_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000518298","article-title":"Adjuvant radiotherapy for extrahepatic cholangiocarcinoma: a quality assessment-based meta-analysis","volume":"10","author":"Choi","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clim.2026.110780_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113564","article-title":"Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives","volume":"199","author":"Ten Haaft","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11864-023-01153-5","article-title":"Current standards, multidisciplinary approaches, and future directions in the management of extrahepatic cholangiocarcinoma","volume":"25","author":"Wheless","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12876-025-03979-9","article-title":"The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients","volume":"25","author":"Dayyan","year":"2025","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-025-01515-8","article-title":"Blocking CXCR4(+) CD4(+) T cells reprograms Treg-mediated immunosuppression via modulating the Rho-GTPase\/NF-\u03baB signaling axis","volume":"17","author":"Cao","year":"2025","journal-title":"Genome Med."},{"issue":"10","key":"10.1016\/j.clim.2026.110780_bb0065","article-title":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8(+) T cells via JAK2\/STAT3 pathway","volume":"4","author":"Cao","year":"2024","journal-title":"Cell Genom."},{"issue":"7982","key":"10.1016\/j.clim.2026.110780_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b2(1)-adrenergic receptor links sympathetic nerves to Tcell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clim.2026.110780_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101184","article-title":"Anti-TIGIT therapies for solid tumors: a systematic review","volume":"8","author":"Rousseau","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07984-4","article-title":"TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Dis."},{"issue":"23","key":"10.1016\/j.clim.2026.110780_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312848","article-title":"Tumor microenvironment drives the cross-talk between co-stimulatory and inhibitory molecules in tumor-infiltrating lymphocytes: implications for optimizing immunotherapy outcomes","volume":"25","author":"Franzese","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clim.2026.110780_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41419-025-07388-4","article-title":"TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8+ T cell exhaustion: implications for immunotherapy","volume":"16","author":"Tang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.clim.2026.110780_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1158\/2326-6066.CIR-25-0743","article-title":"Ex vivo immuno-oncology platform reveals spatial T-cell infiltration patterns linked to ATR inhibition responses in high-grade serous ovarian cancer","volume":"14","author":"Sakrepatna Nagaraj","year":"2026","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.clim.2026.110780_bb0100","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.immuni.2025.06.001","article-title":"The costimulatory molecule ICOS limits memory-like properties and function of exhausted PD-1(+)CD8(+) T cells","volume":"58","author":"Humblin","year":"2025","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.clim.2026.110780_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071652","article-title":"PI3K\/AKT signaling tips the balance of cytoskeletal forces for cancer progression","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.clim.2026.110780_bb0110","first-page":"C977","article-title":"Kinetics of nuclear-cytoplasmic translocation of Foxo1 and Foxo3A in adult skeletal muscle fibers","volume":"303","author":"Schachter","year":"2012","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.clim.2026.110780_bb0115","article-title":"CD8(+) T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"6734","key":"10.1016\/j.clim.2026.110780_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj3020","article-title":"Nutrient-driven histone code determines exhausted CD8(+) T cell fates","volume":"387","author":"Ma","year":"2025","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.clim.2026.110780_bb0125","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.neuron.2025.09.005","article-title":"Targeting tumor-associated nerves enhances cancer immunotherapy","volume":"113","author":"Cao","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.clim.2026.110780_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trsl.2022.08.003","article-title":"Next generation patient derived tumor organoids","volume":"250","author":"Podaza","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.clim.2026.110780_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1757516","article-title":"Patient-derived organoids (PDOs): a novel preclinical platform to overcome challenges in cancer immunotherapy","volume":"14","author":"Ni","year":"2026","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162600118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162600118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:49:09Z","timestamp":1791744549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162600118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"alternative-id":["S152166162600118X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110780","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIGIT regulates CD8+T cell exhaustion via the PI3K\/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110780"}}